The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Microdosing technology overview
Discover our microdosing capabilities for your clinical manufacturing
Video
Thermo Fisher Scientific is revolutionizing clinical trial drug manufacturing with its innovative drug-in-capsule approach—an advanced, solution free of preformulation that doses API directly into capsules, eliminating traditional formulation steps. This cutting-edge microdosing technology minimizes waste, reduces analytical efforts, and accelerates timelines, all while preserving valuable API—critical for early-phase trials.
Available globally through our Basel, Switzerland site, the platform supports precise dosing as low as 1 mg, handles complex drug properties, and seamlessly scales from Phase I to commercialization. Backed by over 35 years of experience and a global network of 30 cGMP facilities, Thermo Fisher delivers integrated, end-to-end solutions that simplify and accelerate the journey from clinical development to commercialization. Watch our video showcasing what’s possible in clinical trial manufacturing to help you on your clinical trial journey.